Related Experiment Video
Updated: May 12, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Testosterone levels following decreases in serum osteocalcin
Mark J Bolland1, Andrew Grey, Anne M Horne
1Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, 1142, New Zealand. m.bolland@auckland.ac.nz
Zoledronate significantly reduced osteocalcin levels in men, but did not affect testosterone or luteinizing hormone. This suggests osteocalcin does not play a major role in regulating testosterone in adult men.
Area of Science:
- Endocrinology
- Bone Metabolism
- Men's Health
Background:
- Preclinical studies suggest osteoblasts induce testosterone production via osteocalcin.
- Bisphosphonates, like zoledronate, reduce osteocalcin levels.
- The impact of bisphosphonate-induced osteocalcin reduction on male testosterone is unclear.
Purpose of the Study:
- To investigate the relationship between osteocalcin and testosterone levels in men.
- To determine if zoledronate treatment affects testosterone levels in HIV-infected men.
- To assess the role of osteocalcin in regulating testosterone in adult males.
Main Methods:
- A 2-year randomized, controlled trial of zoledronate in HIV-infected men.
- Measurement of serum testosterone, luteinizing hormone, and total osteocalcin.
- Comparison of hormone and osteocalcin levels between zoledronate and placebo groups.
Main Results:
- Zoledronate significantly reduced total osteocalcin by 39% at 2 years (P=0.003).
- No significant changes in testosterone or luteinizing hormone over time or between groups.
- Absence of testosterone changes despite reduced osteocalcin levels.
Conclusions:
- Osteocalcin reduction by zoledronate does not impact testosterone levels in adult men.
- Osteocalcin is unlikely to be a significant regulator of testosterone in this population.
- Men on bisphosphonates are unlikely to develop iatrogenic hypogonadism.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Testosterone: Functions and Regulation
Bone Remodeling
Menopause
